









































































































































































































































































































































































































































































































































































1. Introduction1  
1.1 The human genome 
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2Table adapted from Cirulli et al. [2]. 
!
Table 1. Frequencies of variants in the human population. 
 
Variant 
Category Minor allele frequency (MAF) Implications for genetic analyses 
Common 5-50% Used in traditional GWA studies 
Less Common 1-5% Variants catalogued more recently and included in the newest GWA chips for association testing 
Rare Less than 1% but polymorphic in one or more major human populations 
Detectable by NGS and amenable to analysis for 
case-control, family, or trio based studies 
Private 
Much less than 1% and found only in a 
single or a handful of analyzed samples 
and their immediate relatives 
Difficult to gather statistical evidence except 
through co-segregation in families 
 


























1.2 Identifying genetic determinants of human phenotypes 









































































































































































































































































































































Symbol Gene Description 
Cytogenetic 





ARX Aristaless-related homeobox, X-linked Xp21.3 Epileptic encephalopathy, early infantile, 1 308350 XR 
CDKL5 Cyclin-dependent kinase-like 5 Xp22.13 Epileptic encephalopathy, early infantile, 2 300672 XD 
CHRNA2 Cholinergic receptor, nicotinic, alpha polypeptide-2 8p21.2 Epilepsy, nocturnal frontal lobe, type 4 610353 AD 
CHRNA4 Cholinergic receptor, nicotinic, alpha polypeptide-4 20q13.33 Epilepsy, nocturnal frontal lobe, 1 600513 AD 
CHRNB2 Cholinergic receptor, nicotinic, beta polypeptide-2 1q21.3 Epilepsy, nocturnal frontal lobe, 3 605375 AD 
GABRG2 Gamma-aminobutyric acid (GABA) A receptor, gamma-2 5q34 Epilepsy, generalized, with febrile seizures plus, type 3; Febrile seizures, familial, 8 
611277; 
611277 AD; AD 
KCNMA1 
Potassium large conductance calcium-activated channel, 
subfamily M, alpha member 1 (slowpoke, Drosophila, 
homolog of) 
10q22.3 Generalized epilepsy and paroxysmal dyskinesia  609446 AD 
KCNQ2 Potassium voltage-gated channel, KQT-like subfamily, member 2 20q13.33 
Seizures, benign neonatal, 1; Epileptic encephalopathy, 
early infantile, 7 
121200; 
613720 AD; AD 
KCNQ3 Potassium voltage-gated channel, KQT-like subfamily, member 3 8q24.22 Seizures, benign neonatal, type 2 121201 AD 
LGI1 Leucine-rich gene, glioma-inactivated, 1 10q23.33 Epilepsy, familial temporal lobe, 1 600512 AD 
PCDH19 Protocadherin 19 Xq22.1 Epileptic encephalopathy, early infantile, 9 300088 X 
SCN1A Sodium channel, voltage-gated, type I, alpha polypeptide 2q24.3 Epilepsy, generalized, with febrile seizures plus, type 2 604403 AD 
SCN1B Sodium channel, voltage-gated, type I, beta polypeptide 19q13.12 Epilepsy, generalized, with febrile seizures plus, type 1 604233 AD 
SCN2A Sodium channel, voltage-gated, type II, alpha subunit 2q24.3 Seizures, benign familial infantile, 3; Epileptic encephalopathy, early infantile, 11 
607745; 
613721 AD; AD 
SLC2A1 Solute carrier family 2 (facilitated glucose transporter), member 1 1p34.2 

















Symbol Gene Description 
Cytogenetic 





ALDH7A1 Aldehyde dehydrogenase 7 family, member A1 5q23.2 Epilepsy, pyridoxine-dependent 266100 AR 
ALG13 Alg13, S. cerevisiae, homolog of Xq23 Epileptic encephalopathy (not in OMIM yet) N/A XD 
ARHGEF9 Rho guanine nucleotide exchange factor 9 Xq11.1- q11.2 Epileptic encephalopathy, early infantile, 8 300607 XR 
ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 8p22 Spinal muscular atrophy with progressive myoclonic epilepsy 159950 AR 
CHD2 Chromodomain helicase DNA binding protein-2 15q26.1 Epileptic encephalopathy, childhood-onset 615369 AD 
CLN8 CLN8 gene 8p23.3 Northern epilepsy variant 610003 AR 
CNTNAP2 Contactin-associated protein-like 2 7q35-q36 Cortical dysplasia-focal epilepsy syndrome 610042 AR 





CSTB Cystatin B (stefin B) 21q22.3 Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg) 254800 AR 
DEPDC5 DEP domain-containing protein 5 22q12.2- q12.3 Epilepsy, familial focal, with variable foci 604364 AD 
EPM2A Laforin 6q24.3 Epilepsy, progressive myoclonic 2A (Lafora) 254780 AR 
GABRB3 Gamma-aminobutyric acid (GABA) A receptor, beta-3 15q12 Epileptic encephalopathy (not in OMIM yet) N/A AD 
GNAO1 Guanine nucleotide-binding protein (G protein), alpha-activating activity 16q12.2 Epileptic encephalopathy, early infantile, 17 615473 AD 
GOSR2 Golgi snap receptor complex member 2 17q21.32 Epilepsy, progressive myoclonic 6 614018 AR 
GRIN2A Glutamate receptor, ionotropic, N-methyl D-aspartate 2A 16p13.2 Epilepsy, focal, with speech disorder and with or without mental retardation 245570 AD 
IER3IP1 Immediate-early response 3-interacting protein 1 18q21.1 Microcephaly, epilepsy, and diabetes syndrome 614231 AR 





KCTD7 Potassium channel tetramerization domain containing 7 7q11.21 Epilepsy, progressive myoclonic 3, with or without intracellular inclusions 611726 AR 
MEF2C MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) 5q14.3 
Mental retardation, stereotypic movements, epilepsy, 
and/or cerebral malformations 613443 AD 
NHLRC1 NHL repeat-containing 1 gene (malin) 6p22.3 Epilepsy, progressive myoclonic 2B (Lafora) 254780 AR 
PLCB1 Phospholipase C, beta-1 20p12.3 Epileptic encephalopathy, early infantile, 12 613722 AR 
PNKP Polynucleotide kinase 3' phosphatase 19q13.33 Epileptic encephalopathy, early infantile, 10 613402 AR 
PRICKLE1 Prickle-like 1 12q12 Epilepsy, progressive myoclonic 1B 612437 AR 
PRICKLE2 Prickle-like 2 3p14.1 Epilepsy, progressive myoclonic 5 613832 AD 













Symbol Gene Description 
Cytogenetic 





SCN8A Sodium channel, voltage gated, type VIII, alpha polypeptide 12q13.13 Epileptic encephalopathy, early infantile, 13 614558 AD 





SIAT9 Sialyltransferase 9 2p11.2 Amish infantile epilepsy syndrome 609056 AR 
SLC25A22 Solute carrier family 25 (mitochondrial carrier, glutamate), member 22 11p15.5 Epileptic encephalopathy, early infantile, 3  609304 AR 
SNIP1 SMAD nuclear interacting protein 1 1p34.3 Psychomotor retardation, epilepsy, and craniofacial dysmorphism 614501 AR 
SPTAN1 Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin) 9q34.11 Epileptic encephalopathy, early infantile, 5 613477 AD 
SRPX2 SUSHI repeat-containing protein, X-linked, 2 Xq22.1 Rolandic epilepsy, mental retardation, and speech dyspraxia 300643 X 





STRADA STE20-related kinase adaptor alpha 17q23.3 Polyhydramnios, megalencephaly, and symptomatic epilepsy 611087 AR 
SYN1 Synapsin I Xp11.23 Epilepsy, X-linked, with variable learning disabilities and behavior disorders 300491 X 
SYNGAP1 Synaptic Ras GTPase activating protein 1 6p21.32 Epileptic encephalopathy (not in OMIM yet)  N/A AD 
SZT2 Seizure threshold 2, mouse, homolog of 1p34.2 Epileptic encephalopathy, early infantile, 18  615476 AR 



















































































































































































































































































































































































































































































2. Deficiency of Asparagine Synthetase Causes 



























2.2 Materials and Methods 






























































































































































































































The! pdb! structure! was! made! using! Discovery! Studio! program! (http://!
accelrys.com/products/discoveryMstudio)!(Figure!11).!!
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Table 1. Clinical Features of Patients with Mutations in ASNS
Family A Family B Family C Family D
Consanguinity Yes No Yes No
Ethnic origin Iranian Jews Iranian Jews Bangladeshi French Canadian
Subjects A.II.1 B.II.2 B.II.4 C.II.1 C.II.3 C.II.4 D.II.1 D.II.2 D.II.3





Gender Male Male Female Male Male Male Male Male Male
Age 14 years 14 years 12 years 4 monthsy 3 monthsy 6 monthsy 9 daysy 11 monthsy 12 monthsy










Severe Severe Severe Severe Severe Severe Severe Severe Severe
Progressive
microcephaly
Yes Yes Yes Yes Yes Yes NA Yes Yes
Epilepsy
Age at onset 1 month 2 weeks 3 weeks None None None 4 days 9 months5 8 days
























Axial hypotonia No No No No Yes Yes Yes Yes Yes
Appendicular
hypertonia
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Hyperreflexia Yes Yes Yes Yes Yes Yes Yes Yes Yes




Yes Yes Yes Yes Yes Yes Yes Yes Yes
Decreased size
of pons
No No No Yes Yes Yes Yes Yes Yes
simplified gyri No No No Yes Yes Yes Yes Yes Yes
yDeceased; 1head circumference; 2born at 33.5 weeks of gestation; 3generalized tonic-clonic seizures; 4multiple independent spike foci; 5tremulous movements and abnormal EEG at 4 days;
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Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. 
SUPPLEMENTAL DATA: TABLES  
Supplementary Table 1. All rare variants shared in both patients from family B. !
Functional category Homozygous Heterozygous 
Essential splice site 1 2 
Intron-exon boundary (SNV) 10 32 
Intron-exon boundary (indel) 1 9 
Non-synonymous coding 58 248 
Stop gained 1 5 
Coding-disrupted frameshift (indel) 1 8 
Coding-disrupted other (indel) 0 2 
Total 72 306 
 
Supplementary Table 1. All rare variants shared in both patients from family B. A summary of all rare 
variants, with a plausible impact on the function of the resulting gene product, shared in family B (found in both 
affected individuals II.2 and II.4). A rare variant was defined as having a predicted homozygote frequency of ≤ 3% 
























Supplementary Table 2. All rare homozygous functional variants found in both patients from family B. !
Variant Variant ID Variant type Gene symbol 
Variant 
frequency  Variant Variant ID 
Variant 
type Gene symbol 
Variant 
frequency 
1 7_97322654_C SNV ASNS 0.000   37 9_39075808_C SNV CNTNAP3 0.117 
2 7_107186210_T SNV CBLL1 0.000   38 19_38355194_C SNV WDR88 0.119 
3 7_107475774_C SNV LAMB4 0.000   39 19_59416242_A SNV LILRB3 0.119 
4 7_106296855_T SNV PIK3CG 0.002   40 22_44146055_T SNV SMC1B 0.121 
5 6_41721834_A SNV MDFI 0.004   41 X_1497953_T SNV ASMTL 0.121 
6 12_51248317_A SNV KRT74 0.006   42 12_48631243_A SNV AQP2 0.123 
7 7_106725874_C SNV COG5 0.008   43 16_2045401_T SNV TSC2 0.123 
8 19_38307917_T SNV GPATCH1 0.010   44 15_19884068_C SNV OR4N4 0.123 
9 7_104993051_A SNV RINT1 0.012   45 6_32740678_A SNV HLA-DQB1 0.125 
10 7_98997458_G SNV ZNF655 0.015   46 22_29862960_T SNV PLA2G3 0.127 
11 12_51152337_G SNV KRT6C 0.025   47 X_1500706_G SNV ASMTL 0.127 
12 17_35550980_DEL_T indel CASC3 0.031   48 17_27649318_A SNV RHBDL3 0.129 
13 16_2100974_G SNV PKD1 0.044   49 X_1506842_G SNV ASMTL 0.129 
14 17_41416696_G SNV MAPT 0.046   50 11_77586662_A SNV USP35 0.131 
15 7_107004256_A SNV DUS4L 0.048   51 22_30919090_T SNV RFPL2 0.131 
16 6_24511434_T SNV MRS2L 0.050   52 19_59416243_A SNV LILRB3 0.135 
17 18_12244956_A SNV CIDEA 0.054   53 16_2105631_C SNV PKD1 0.137 
18 7_102361951_G SNV LRRC17 0.054   54 20_10551750_A SNV C20orf94 0.138 
19 12_51838742_G SNV CSAD 0.056   55 3_41852418_C SNV ULK4 0.142 
20 7_102452856_G SNV FBXL13 0.056   56 14_20569961_T SNV TPPP2 0.146 
21 19_38209355_T SNV RHPN2 0.060   57 1_151037145_A SNV LCE1D 0.148 
22 7_101885015_A SNV ALKBH4 0.062   58 12_51503256_A SNV KRT79 0.148 
23 19_13901896_A SNV CC2D1A 0.079   59 1_37961428_A SNV EPHA10 0.160 
24 16_2102362_G SNV PKD1 0.083   60 10_18868641_G SNV CACNB2 0.160 
25 16_2095427_C SNV PKD1 0.087   61 7_29127129_T SNV CPVL 0.162 
26 7_99655521_T SNV PVRIG 0.102   62 19_37859295_T SNV RGS9BP 0.162 
27 1_37958776_T SNV EPHA10 0.104   63 15_41604696_A SNV MAP1A 0.163 
28 7_100324690_C SNV UFSP1 0.104   64 16_2092388_G SNV PKD1 0.165 
29 8_17202048_G SNV MTMR7 0.104   65 6_31432179_C SNV HLA-B 0.169 
30 18_59805277_G SNV SERPINB8 0.104   66 15_19884261_G SNV OR4N4 0.169 
31 3_62164229_A SNV PTPRG 0.108   67 1_75475262_A SNV SLC44A5 0.171 
32 1_159963696_C SNV FCRLB 0.110   68 2_111315429_T SNV ACOXL 0.171 
33 6_109430212_T SNV SESN1 0.110   69 11_77598578_G SNV USP35 0.173 
34 X_152517671_INS_C indel FAM58A 0.112   70 3_47427122_A SNV PTPN23 0.175 
35 12_51330534_T SNV KRT2 0.115   71 2_238675316_C SNV ESPNL 0.179 
36 6_109587255_C SNV C6orf182 0.117   72 17_35133114_G SNV ERBB2 0.179 
           
Supplementary Table 2. All rare homozygous functional variants found in both patients from family B. The 72 homozygous functional variants found 
in both II.2 and II.4 of family B. The variants are listed in ascending order based on the variant allele frequency in the sequenced control population. The 







































Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. 
 
Supplementary Table 3. Regions of shared homozygosity in Family C. 
 
Chr Marker start Marker end Position start Position end Size (Mb) 
1 rs3863722 
 
rs272822 35,592,376 36,677,585 1.1 
1 rs319950 
 
rs9436447 49,091,687 50,590,732 1.5 
3 rs3895736 
 
rs3197999 48,658,467 49,721,532 1.1 
3 rs9790150 
 
rs2882429 133,723,028 139,835,865 6.1 
4 rs10517277 
 
rs6858830 33,466,803 34,500,856 1.0 
5 rs10477652 
 
rs10478752 123,179,118 126,087,378 2.9 
7 rs11773446 
 
rs7780168 95,944,485 131,291,677 35.3 
12 rs1564121 
 
rs12311684 86,138,548 89,435,177 3.3 
 
Supplementary Table 3. Regions of shared homozygosity (>1Mb) between the affected individuals in Family C 
(II.3 and II.4). 
 
 
Supplementary Table 4. Exome sequencing variant filtering in family C. 
 
Filter Remaining variants 
Coding /Splicing 20,439 
Remove synonymous (non-splicing) 10,175 
Rare* 856 
Homozygous 25 
In homozygous region 3 




Predicted damaging (SIFT or polyphen-2) ASNS:NM_183356:exon14:c.C1648T:p.R550C 
 
Supplementary Table 4. Exome sequencing variant filtering in family C. *Rare variants were defined as those 
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Supplementary Table 3. Regions of shared homozygosity in Family C. 
 
Chr Marker start Marker end Position start Position end Size (Mb) 
1 rs3863722 
 
rs272822 35,592,376 36,677,585 1.1 
1 rs319950 
 
rs9436447 49,091,687 50,590,732 1.5 
3 rs3895736 
 
rs3197999 48,658,467 49,721,532 1.1 
3 rs9790150 
 
rs2882429 133,723,028 139,835,865 6.1 
4 rs10517277 
 
rs6858830 33,466,803 34,500,856 1.0 
5 rs10477652 
 
rs10478752 123,179,11  126,087,378 2.9 
7 rs11773446 
 
rs7780168 95,944,485 131,291,677 35.3 
12 rs1564121 
 
rs12311684 86,138,548 89,435,177 3.3 
 
Supplementary Table 3. Regions of shared homozygosity (>1Mb) between the affected individuals in Family C 
(II.3 and II.4). 
 
 
Supplementary Table 4. Exome sequencing variant filtering in family C. 
 
Filter Remaining variants 
Coding /Splicing 20,439 
Remove synonymous (non-splicing) 10,175 
Rare* 856 
Homozygous 25 
In homozygous region 3 
Segregating with the disease in the homozygous state ASNS:NM_183356:exon14:c.C1648T:p.R550C CYP3A4:NM_017460:exon12:c.G1282A:p.D428N 
Predicted damaging (SIFT or polyphen-2) ASNS:NM_183356:exon14:c.C1648T:p.R550C 
 
Supplementary Table 4. Exome sequencing vari t filtering in family C. *Rare variants were defined as those 






















Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. 
 
! 10!
Supplementary Table 5. Exome sequencing variant filtering in family D. 
 





 II.1 II.2 II.4 II.5 
Coding/Splicing 20,336 21,120 19,325 20,252 
Remove synonymous (non-splicing) 10,021 10,491 9,793 10,363 
Shared by II.1 and II.2 7,830   
Rare* 237   
Homozygous in II.1 & II.2 but not homozygous in II.4 or 
II.5 0   
Variants on chr X in II.1 and II.2 but not in II.4 0   
Genes with ≥2 rare variants in common to II.1 & II.2 14   
Genes with ≥2 rare variants in common to II.1 & II.2 but 
not in common with II.4 or II.5 (compound heterozygous). 
ASNS (NM_183356)  
c.C1648T:p.R550C 
c.C17A:p.A6E   
 
Supplementary Table 5. Exome sequencing variant filtering in family D. Rare variants were defined as those 




Supplementary Table 6. F362V ASNS shared haplotype in families A and B. 
 
SNV Coordinate Alleles 
1 chr7:97322654 C/C 
2 chr7:97325666 A/A 
3 chr7:97326505 T/T 
4 chr7:97621997 C/C 
5 chr7:97654263 T/T 
6 chr7:97660051 A/A 
7 chr7:97660146 A/A 
8 chr7:97760787 T/T 
9 chr7:97760811 A/A 
10 chr7:97771537 T/T 
11 chr7:97782680 A/A 
12 chr7:98298760 A/A 
13 chr7:98338892 T/T 
14 chr7:98396816 C/C 
15 chr7:98487987 C/C 
16 chr7:98488035 C/C 
 
Supplementary Table 6. The shared F362V ASNS haplotype in families A and B. The 16 variants found in the 
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  ..*:. *!   :::****: ***.*    : 
Human MCGIWALFGS! SVVIFSGEGS! DPSARTLTHY 
Mouse MCGIWALFGS! SVVIFSGEGS! DPSARTLTHY 
Lizard MCGIWALFGS! SAVIFSGEGS! DPSARTLTHY 
Chicken MCGIWALFGS! SVVIFSGEGS! DPSARTLTHY 
Fish MCGIWAVFGS! SVVIFSGEGS! DPSARTLTHY 
Fly MCGIFAIFSK! IKMILSGEGA! DPSGRAQAVH 
Yeast MCGIFAAFKI! VKMVLSGEGS! DPSGRYAKIH 
bacteria -ASIFGVFDA! IKMVLSGEGS! DPSGRAVGVH 
 ! !  
!





































































































































































































































































































































By! comparison,! CONT! and!Asns+/H! animals! preferred! the! novel! object;! however,! LTM!
was!still!reduced!in!the!AsnsH/H!mice.!It!should!be!emphasized!that!the!deficits!in!STM!or!
LTM!by!the!mutants!were!not!related! to! the! total! time!spent!with! the!objects!or! to! the!
total!numbers!of!object!contacts! (Figure!20! (FHG)).!Collectively,! these!data! indicate! that!
AsnsH/H!mice!are! impaired! in!both!STM!and!LTM.!By!contrast,! there! is! some!sparing!of!
































































































































































































3.2 Materials and methods 

























































































































































Variant 1 (Gene A):
Variant 2 (Gene A):
62 trios
Exome sequencing
Identify genes with qualifying mutations










Functional characterization of the variant’s 
impact on encoded gene product (n=4)
Genetic diagnosis 
for 20 trios
Possible genetic diagnosis 
for 12 trios*
No genetic diagnosis for 
30 trios
B.
Alignment and variant calling
C. 62 trios
Exome sequencing
Identify de novo mutations 
using trio aware calling
Alignment and variant calling
Eliminate 14 patients with inherited causal 
variants
9 de novo mutations in the hot zone
5 causal 
mutations 
2 possibly causal 
mutation
2 mutations of unclear 
clinical significance
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● ● ● ● ●Causal (n=5) Causal, previous study (n=3) DNM EFTUD2 MAGI1




























Table 2: De novo mutations with both extreme gene-level score (residual variation intolerance score (RVIS)7 ≤ 
25%) and variant-level scores (PolyPhen-2 quantitative score ≥ 0.95) 




based on previous 
studies 
8 chr2:127826559 BIN1 probably damaging (1) 13.6 Unknown 
10 chr20:62071037 KCNQ2 probably damaging (0.995) 15.9 Causal 
33 chr18:31323963 ASXL3 frameshift variant (1) 15.9 Causal 
41 chr13:26127983 ATP8A2 nonsense (1) 6.9 Maybe causal 
46 chr16:56226491 GNAO1 probably damaging (1) 13.9 Causal 
50a chr1:27432470 SLC9A1 probably damaging (0.992) 2.9 Unknown 
56 chr9:138669220 KCNT1 probably damaging (1) 1.6 Causal 
N6 chr1:245020159 HNRNPU Splice site variant (1) 17.6 Maybe causal 
N12 chr16:30748691 SRCAP nonsense (1) 0.2 Causal 
N12b chr11:47290219 NR1H3 probably damaging (1) 16.4 Unlikely 
 
aIn addition to family 50, another hot zone de novo mutation (N266H) was seen in SLC9A1 in a patient not included 
in this study that presented with spastic diplegia, autism, seizures, ID, behavioral problems and possible Worster-
Drought syndrome. The phenotype was not similar enough to patient 50 for us to declare this as causal in either case. 
bN12 had two de novo mutations in the hot zone, of which, SRCAP was assessed more damaging of the two based 
on Eucledian distance from [1,0], thus only SRCAP included in the 2D plot. Evidence for disease-associations based on 









































































































































































































































4.2.6 Application of the gene-specific mutation rate calculation to 
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Gene  Chr Average effectively captured length (bp) 
Gene-specific 





P valuea  
SCN1A 2 6,064 1.61 X 10-4 5b 1.12 X 10-9 *** 
STXBP1 9 1,918 6.44 X 10-5 5 1.16 X 10-11 *** 
GABRB3 15 1,207 3.78 X 10-5 4 4.11 X 10-10 *** 
CDKL5 X 2,798 5.44 X 10-5 3 4.90 X 10-7 ** 
ALG13c X 475 1.03 X 10-5 2 7.77 X 10-12 *** 
DNM1 9 2,323 9.10 X 10-5 2 2.84 X 10-4  
HDAC4 2 2,650 1.16 X 10-4 2 4.57 X 10-4  
SCN2Ac 2 5,831 1.52 X 10-4 2 1.14 X 10-9 *** 



















that can confer risk of epileptic encephalopathies and that each muta-
tion carries substantial risk. We also found that putatively damaging
de novo variants in our cohort are significantly enriched in intolerant
genes compared with control cohorts (Supplementary Methods).
We next evaluated whether the de novomutations were drawn pre-
ferentially from six gene sets (Methods and Supplementary Table 10),
including ion channels22, genes known to cause monogenic disorders
with seizures as a phenotypic feature23, genes carrying confirmed de
novomutations in patients with autism spectrum disorder2,8,19,20 and in
patients with intellectual disability18,24, and FMRP-regulated genes.
Taking into account the size of regionswith adequate sequencing cover-
age to detect a de novomutation (Methods), we found significant over-
representation for all gene lists in our data (Supplementary Table 10),
and no over-representation in controls2,19,20,24.
To determine possible interconnectivity among the genes carrying
a de novomutation, we performed a protein–protein interaction ana-
lysis and identified a single network of 71 connected proteins (Fig. 2
and Supplementary Fig. 7). These 71 proteins include six encoded by
OMIM reported epileptic encephalopathy genes (http://www.omim.
org/) where we identified one or more de novo mutations among the
epileptic encephalopathy patients in this study. Genes in this protein–
protein network were also found to have a much greater probability of
overlapwith the autism spectrumdisorder2,8,19,20 and severe intellectual
disability disorder18,24 exome sequencing study genes, andwith FMRP-
associatedgenes, thangenesnot in thisnetwork (SupplementaryTable11).
In support of a hypothesis that individual raremutations in different
genes may converge on biological pathways, we draw attention to six
mutations that all affect subunits of the GABA (c-aminobutyric acid)
ionotropic receptor (four in GABRB3, and one each in GABRA1 and
GABRB1), and highlight two interactions: HNRNPU interacting with
HNRNPH1, and NEDD4L (identified here) binding to TNK2, a gene
previously implicated in epileptic encephalopathies25 (Fig. 2). Although
the HNRNPU mutation observed here is a small insertion/deletion
variant (indel) in a splice acceptor site, and therefore probably results
in amodified protein, theHNRNPH1 de novomutation is synonymous
and thus of unknown functional significance (Supplementary Table 2).
Notably, a minigene experiment indicates that this synonymous muta-
tion induces skipping of exon 12 (Supplementary Methods).
Evaluation of the clinical phenotypes among patients revealed sig-
nificant genetic heterogeneity underlying infantile spasmsandLennox–
Gastaut syndrome, and begins to provide information about the range
of phenotypes associated withmutations in specific genes (Supplemen-
tary Table 13).We identified four genes—SCN8A, STXBP1,DNM1 and
GABRB3—with de novo mutations in both patients with infantile
spasms and patients with Lennox–Gastaut syndrome. Although infant-
ile spasmsmay progress to Lennox–Gastaut syndrome, in three of these
cases the patients with Lennox–Gastaut syndrome did not initially
present with infantile spasms, indicating phenotypic heterogeneity
associated with mutations in these genes yet supporting the notion of
shared genetic susceptibility. Notably, inmultiple patients we identified
denovomutations in genespreviously implicated inotherneurodevelop-
mental conditions, and in some cases with very distinctive clinical pre-
sentations (Supplementary Table 12).Most notably, we found a denovo
mutation inMTOR, a gene recently found to harbour a causal variant
inmosaic form in a casewith hemimegalencephaly26. Our patient how-
ever showednodetectable structural brainmalformation. Similarly, we
found one patient with a de novomutation inDCX and another with a
de novo mutation in FLNA, previously associated with lissencephaly
andperiventricular nodularheterotopia, respectively27,28; neither patient
had cortical malformations detected on magnetic resonance imaging.
In addition to de novo variants, we also screened for highly penetrant
genotypes by identifying variants that create newly homozygous, com-
poundheterozygous, or hemizygous genotypes in the probands that are
not seen in parents or controls (SupplementaryMethods). No inherited
variants showed significant evidence of association. Additional studies
evaluating a larger number of epileptic encephalopathy patients will be
required to establish the role of inherited variants in the disease risk
associated with infantile spasms and Lennox–Gastaut syndrome.
We have identified novel de novomutations implicating at least two
genes for epileptic encephalopathies, and also describe a genetic archi-
tecture that strongly suggests that we have identified additional causal
mutations in genes intolerant to functional variation. Given that our
sample size already shows many genes with recurrent mutations, it is
clear that evenmodest increases in sample sizeswill confirmmanynew
genes now seen in only one of our trios.Our results also emphasize that
itmay be difficult to predict with confidence the responsible gene, even
among known genes, based upon clinical presentation. This makes it
clear that the future of genetic diagnostics in epileptic encephalopathies
will need to focus on the genome as a whole as opposed to single genes
or even gene panels. In particular, several of the genes with de novo
mutations in our cohort have also been identified in patients with
Table 1 | Probability of observing the reported number of de novomutations by chance in genes recurrently mutated in this cohort







SCN1A 2 6,063.70 1.61 31024 5{ 1.12 31029 ***
STXBP1 9 1,917.51 6.44 31025 5 1.16 310211 ***
GABRB3 15 1,206.86 3.78 31025 4 4.11 310210 ***
CDKL5 X 2,798.38 5.44 31025 3 4.90 31027 **
ALG131 X 475.05 1.03 31025 2 7.77 310212 ***
DNM1 9 2,323.37 9.10 31025 2 2.84 31024
HDAC4 2 2,649.82 1.16 31024 2 4.57 31024
SCN2A1 2 5,831.21 1.52 31024 2 1.14 31029 ***
SCN8A 12 5,814.48 1.64 31024 2 9.14 31024
{Adjusted a is equivalent to 0.05/18,09152.76 31026 (*), 0.01/18,09155.53 31027 (**) and 0.001/18,09155.53 31028 (***).
{Counts exclude three additional patients with an indel or splice site mutation as these are not accounted for in the mutability calculation.
1Two de novomutations occur at the same position. The probability of these special cases obtain P57.77 310212 and P51.14 31029 for ALG13 and SCN2A, respectively (Methods).
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Figure 1 | Heat map illustrating the probability of observing the specified
number of de novo mutations in genes with the specified estimated
mutati n rate. The number of de novo mutations required o achieve
significance is indicated by the solid re line. The superimposed dots reflect
positions of all genes found to harbourmultiple de novomutations in our study.
GABRB3, SCN1A, CDKL5 and STXBP1 have significantly more de novo
mutations than expected. The positions indicated forALG13 and SCN2A reflect
only the fact that there are two mutations observed, not that there are two
mutations affecting the same site (Methods).
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4.3.5 Cross-study validation of genes previously associated with 
































































ALG13 #! X 3,641 4.73 x10-5 2 X_110928268_A/G, X_110928268_A/G 368 1.75 x 10-11; 4.38 x 10-12 *** 





1,021 8.43 x 10-12 *** 




435 1.01 x 10-11 *** 
GABRB3 15 1,573 2.66 x10-5 4 15_26866594_T/C, 15_26866564_C/T, 15_26828484_T/C, 15_26806254_T/C 366 6.12 x 10
-9 *** 




651 5.12 x 10-10 *** 
GRIN2A 16 4,443 7.47 x10-5 4 16_9923442_C/A, 16_9916208_A/G, 16_9923333_A/G, 16_9934513_C/T 518 1.45 x 10
-6 ** 
GRIN2B 12 4,503 7.60 x10-5 3 12_13768545_C/A, 12_13761694_A/C, 12_13761703_T/A 1,005 5.34 x 10
-4  





872 6.68 x 10-13 *** 
SCN8A 12 6,047 8.86 x10-5 4 12_52180374_C/G, 12_52082568_G/A, 12_52159534_T/A, 12_52200572_A/G 866 2.08 x 10
-5  
SLC35A2 # X 1,367 2.54 x10-5 3 X_48762548_G/A, X_48762503_G/T, X_48762684_G/A* 700 7.37 x10
-6; 9.33 x 10-7 *** 
SPTAN1 9 7,658 1.23 x10-4 0 n/a 431 1  


















emphasizes!that!the!epileptic encephalopathies are genetically highly heterogeneous. 
Large cohorts of well-characterized patients will be needed to identify additional genes 






































































































































































































































































































































































otepia' otepi11221a2' Genome' 3,647,150' 662,821' 1.99' 94.45' 2,831,011,250' 39.55' 62,523,558' 31.77' 95.50%'
otepia' ottmn18410' Genome' 3,574,779' 603,343' 2.04' 97.05' 2,834,010,780' 32.26' 64,680,869' 32.45' 98.79%'
otepib' ottmn16313' Genome' 3,738,998' 598,898' 2.04' 96.32' 2,852,646,236' 27.18' 64,622,306' 28.42' 98.70%'
otepib' otepi12464b2' Genome' 3,915,236' 832,535' 2.00' 94.45' 2,830,921,952' 33.5' 62,579,260' 27.55' 95.58%'
otepic' otepi14138c1' Genome' 3,655,012' 695,434' 2.02' 95.46' 2,832,108,608' 31.34' 63,650,458' 26.55' 97.22%'
otepic' otepi13696c2' Genome' 3,719,501' 699,253' 1.96' 93.27' 2,833,599,838' 56.49' 64,640,764' 49.04' 98.73%'
otepid' otepi15449d1' Genome' 3,645,717' 684,065' 1.99' 94.28' 2,831,798,486' 44.22' 63,548,328' 37.08' 97.06%'
otepid' otepi15075d2' Genome' 3,659,115' 888,041' 1.98' 92.98' 2,832,620,322' 41.63' 64,460,322' 78.21' 98.46%'
otepie' otepi14222e1' Genome' 3,628,631' 805,918' 2.01' 94.91' 2,831,826,162' 40.46' 63,684,138' 77.05' 97.27%'
otepie' otepi14221e2' Genome' 3,664,181' 833,465' 2.02' 95.34' 2,832,968,725' 31.94' 64,417,389' 65.66' 98.39%'
otepif' otepi16923f1' Genome' 3,594,850' 691,921' 2.02' 95.75' 2,832,832,496' 37.95' 62,388,552' 30.7' 95.29%'
otepif' otepi17556f2' Genome' 3,609,789' 687,467' 2.02' 94.64' 2,851,628,888' 37.96' 63,440,191' 32.41' 96.90%'
otepig' otepi15001g1' Genome' 3,635,524' 658,888' 2.02' 95.43' 2,850,637,335' 26.77' 64,219,415' 28.46' 98.09%'
otepig' otepi16934g2' Genome' 3,630,479' 673,152' 2.03' 95.91' 2,835,781,477' 31.88' 63,367,894' 28.98' 96.79%'
otepig' otepi15005g3' Genome' 3,651,292' 663,257' 2.00' 94.58' 2,830,470,161' 41.93' 62,127,057' 33.21' 94.89%'
otepih' otepi18345h1' Genome' 3,628,439' 691,190' 2.02' 95.32' 2,831,745,685' 33.09' 62,969,484' 27.1' 96.18%'
otepih' otepi18150h2' Genome' 3,623,588' 673,688' 2.03' 95.98' 2,830,956,588' 33.35' 63,190,458' 29' 96.52%'
otepi' otepi9778i1' Genome' 3,671,785' 707,778' 2.01' 95.18' 2,835,646,283' 38.54' 64,383,387' 34' 98.34%'
otepi' otepi743i2' Genome' 3,640,259' 681,110' 2.00' 95.42' 2,851,369,814' 32.91' 63,740,767' 30.21' 97.36%'
otepij' otepi10843j1' Exome' 36,336' 2,444' 2.88' 98.43' N/A' N/A' 36,623,435' 97.49' 95.50%'
otepij' otepi10694j2' Exome' 35,456' 2,436' 2.84' 98.53' N/A' N/A' 36,825,236' 94.89' 96.20%'
otepik' otepi14411k1' Genome' 3,671,098' 679,737' 2.02' 95.42' 2,830,930,704' 33.98' 62,699,084' 27.58' 95.77%'
otepik' otepi14541k2' Genome' 3,680,517' 683,913' 1.98' 94.26' 2,831,703,148' 34.06' 63,043,727' 28.21' 96.29%'




































otepim' otepi18478m2' Genome' 3,602,777' 637,798' 2.01' 95.16' 2,830,292,911' 39.84' 61,968,573' 31.78' 94.65%'
otepim' otepi17988m3' Genome' 3,631,632' 643,617' 2.03' 95.87' 2,830,861,142' 29.79' 61,812,816' 22.78' 94.41%'
otepin' otepi19602n1' Genome' 3,666,179' 662,978' 2.02' 94.9' 2,831,583,110' 37.26' 62,459,955' 30.21' 95.40%'
otepin' otepi21379n2' Genome' 3,588,936' 636,116' 2.01' 95.46' 2,830,311,497' 32.75' 61,292,225' 26.17' 93.62%'
otepip' otepi9774p1' Genome' 3,708,417' 666,527' 1.98' 93.76' 2,837,113,711' 40.18' 62,665,712' 32.52' 95.72%'
otepip' otepi919p2' Genome' 3,749,585' 676,111' 1.99' 94.15' 2,852,297,905' 36.96' 63,887,233' 33.27' 97.58%'
otepiq' otepi15015q1' Genome' 3,667,565' 665,060' 2.00' 95.27' 2,831,984,577' 36.85' 63,088,699' 30.6' 96.36%'
otepiq' otepi14992q2' Genome' 3,659,215' 662,135' 2.01' 95.37' 2,831,650,948' 40.25' 62,884,721' 33.06' 96.05%'
otepir' otepi10478r1' Genome' 3,652,837' 651,398' 1.99' 94.1' 2,831,310,917' 32.77' 62,436,583' 26.92' 95.37%'
otepir' otepi10818r2' Genome' 3,651,855' 655,863' 1.98' 93.98' 2,830,993,449' 37.93' 62,270,342' 30.45' 95.11%'
otepis' otepi15880s1' Genome' 3,649,015' 666,807' 2.02' 95.31' 2,832,238,734' 42.59' 63,329,691' 35.03' 96.73%'
otepis' otepi18097s2' Genome' 3,637,681' 661,919' 2.00' 94.53' 2,851,518,116' 40.17' 63,148,885' 34.06' 96.45%'
otepit' otepi10425t1' Genome' 3,705,301' 685,331' 1.99' 94.92' 2,843,316,924' 37.97' 64,010,561' 33.11' 97.77%'
otepiu' otepi7861u1' Genome' 3,655,327' 667,318' 1.99' 94.94' 2,852,137,675' 41.39' 63,662,704' 35.86' 97.24%'
otepiv' otepi8884v1' Genome' 3,726,802' 668,044' 2.00' 94.24' 2,832,023,764' 39.04' 63,157,617' 32.34' 96.47%'
otepiw' otepi8089w1' Genome' 3,712,556' 679,454' 1.99' 93.81' 2,850,780,724' 42.07' 62,570,208' 34.66' 95.57%'
otepix' otepi10554x1' Genome' 4,057,788' 722,080' 2.02' 94.91' 2,835,423,639' 40.24' 62,115,344' 32.08' 94.87%'
otepiy' otepi7775y1' Genome' 3,664,915' 670,296' 1.96' 93.58' 2,851,224,467' 39.49' 63,191,960' 33.63' 96.52%'
otepiz' otepi11699z1' Genome' 3,627,107' 651,996' 2.01' 94.66' 2,850,941,642' 39.83' 62,748,765' 33.04' 95.84%'
otepiaa' otepi13345aa1' Genome' 3,653,602' 666,476' 1.99' 94.32' 2,838,280,879' 35.16' 63,315,384' 29.38' 96.71%'
otepibb' otepi13220bb1' Genome' 3,639,471' 657,538' 2.02' 95.47' 2,851,427,988' 40.11' 63,323,293' 34.16' 96.72%'
otepicc' otepi18334cc1' Genome' 3,643,449' 649,554' 2.01' 94.83' 2,831,862,516' 41.57' 62,215,816' 32.89' 95.03%'
otepidd' otepi14568dd1' Genome' 3,594,686' 654,699' 2.02' 95.95' 2,830,812,096' 33.97' 61,465,925' 26.56' 93.88%'
otepiee' otepi15721ee1' Genome' 3,726,866' 673,988' 2.01' 95.09' 2,831,579,624' 39.78' 62,912,817' 32.52' 96.09%'
bkva' bkv5675a1' Exome' 34,811' 2,623' 2.72' 98.23' N/A' N/A' 45,995,153' 44.58' 91.30%'
bkva' bkv5912a2' Exome' 35,545' 2,680' 2.75' 99.08' N/A' N/A' 46,838,420' 68.99' 92.90%'
bkva' bkv2343a3' Exome' 37,563' 2,868' 2.73' 98.87' N/A' N/A' 47,785,934' 59.9' 94.80%'
bkvb' bkv16243b1' Exome' 36,937' 2,838' 2.71' 98.28' N/A' N/A' 47,320,035' 55.6' 93.90%'
bkvb' bkv2347b2' Exome' 37,040' 2,864' 2.67' 98.03' N/A' N/A' 47,482,960' 57.09' 94.20%'


































bkvc' bkv1300c2' Exome' 36,266' 2,753' 2.77' 98.87' N/A' N/A' 46,830,741' 50.72' 92.90%'
bkvd' bkv6443d1' Exome' 35,947' 2,701' 2.74' 98.81' N/A' N/A' 46,989,031' 57.34' 93.20%'
bkvd' bkv7632d2' Exome' 36,200' 2,693' 2.71' 98.31' N/A' N/A' 46,969,942' 48.4' 93.20%'
bkve' bkv187e1' Exome' 36,212' 2,754' 2.78' 98.84' N/A' N/A' 47,233,065' 64.84' 93.70%'
bkve' bkv38e2' Exome' 35,668' 2,730' *' *' N/A' N/A' 47,083,340' 52.65' 93.40%'
bkvf' bkv6622f1' Exome' 37,331' 2,855' 2.75' 98.89' N/A' N/A' 48,017,583' 87.04' 95.30%'
bkvf' bkv6648f2' Exome' 35,442' 2,710' 2.68' 97.92' N/A' N/A' 46,228,345' 42.44' 91.70%'
bkvg' bkv715g1' Exome' 34,790' 2,672' 2.74' 98.54' N/A' N/A' 46,336,880' 44.27' 91.90%'
bkvg' bkv777g2' Exome' 35,408' 2,716' 2.71' 98.88' N/A' N/A' 46,886,201' 50.71' 93.00%'
bkvh' bkv19260h1' Exome' 35,024' 2,577' 2.74' 98.67' N/A' N/A' 46,675,447' 51.69' 92.60%'
bkvh' bkv19263h2' Exome' 35,600' 2,808' 2.77' 98.74' N/A' N/A' 46,536,999' 42.95' 92.30%'
bkvi' bkv8227i1' Exome' 36,980' 2,806' 2.70' 97.93' N/A' N/A' 46,910,734' 50.56' 93.10%'
bkvi' bkv17151i2' Exome' 35,744' 2,735' 2.71' 98.34' N/A' N/A' 46,375,132' 41.65' 92.00%'
bkvj' bkv7065j1' Exome' 36,084' 2,782' 2.77' 99.01' N/A' N/A' 47,386,584' 55.73' 94.00%'
bkvj' bkv7068j2' Exome' 36,141' 2,781' 2.73' 98.41' N/A' N/A' 46,979,440' 49.47' 93.20%''*The'data'for'sample'bkv38e2'was'lost'in'an'attempt'to'convert'to'Genome'Reference'Consortium'Human'Genome'build'37.'
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Percent of Bases Covered (>=3x) across 91 samples



















Average % coverage across samples= 0.9503
Percent of Bases Covered (>=10x) across 91 samples





















Average % coverage across samples= 0.9197
Percent of Bases Covered (>=20x) across 91 samples






















Average % coverage across samples= 0.8952
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ABCC1 ( 34 )
AHNAK ( 27 )
ALS2 ( 36 )
ANK1 ( 47 )
ANK3 ( 55 )
APAF1 ( 28 )
BSN ( 10 )
CACHD1 ( 30 )
CACNA1H ( 35 )
CAD ( 44 )
CELSR1 ( 38 )
CHRNA9 ( 6 )
CLCN3 ( 13 )
CNOT1 ( 49 )
CNOT3 ( 19 )
CNTNAP2 ( 24 )
COL1A1 ( 52 )
COL4A1 ( 58 )
COL7A1 ( 121 )
COLQ ( 19 )
CSMD2 ( 69 )
DOCK1 ( 55 )
DOPEY2 ( 39 )
FLNA ( 47 )
GABRD ( 9 )
GABRG2 ( 11 )
GOLGA3 ( 25 )
GRIN2A ( 13 )
GRM8 ( 11 )
HERC2 ( 100 )
HMCN1 ( 110 )
HTT ( 71 )
ITGAM ( 31 )
KCNQ1 ( 17 )
KIF13A ( 42 )
LGI1 ( 8 )
LRP1 ( 90 )
MBD5 ( 10 )
MCM3AP ( 30 )
MLL2 ( 63 )
MYCBP2 ( 83 )
MYO18B ( 44 )
MYO5A ( 43 )
NDNF ( 3 )
NPC1 ( 25 )
PPM1J ( 10 )
RELN ( 69 )
RYR1 ( 111 )
SACS ( 12 )
SCN10A ( 27 )
SCN1A ( 28 )
SCN1B ( 6 )
SCN2A ( 33 )
SCN9A ( 30 )
SLC32A1 ( 3 )
SLC4A3 ( 22 )
SPEN ( 17 )
SPTAN1 ( 58 )
SZT2 ( 55 )
TBC1D16 ( 11 )
TLN1 ( 57 )
TLN2 ( 58 )
TLR4 ( 6 )
TREX1 ( 1 )
TRIO ( 59 )
UBE3B ( 26 )
VPS13A ( 80 )

























































































































































































































Coverage across gene regions ( 20x ) for Haloplex bkv6464ab1
Average coverage ( 20x ) for Haloplex bkv6464ab1
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Discovery Cohort A (Exome)
Discovery Cohort A (Genome)


































































































































































































































































































































































































































































15 qualifying case variants (6.3%)


















































































































































































































































































































































Appendix A: Additional phenotypic information for 
ASNS deficiency patients 
 
A.1 Comparison to primary microcephaly (MCPH) 
 





















Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. 
 
! 11!
Supplementary Table 7. Summary of exome-sequencing coverage in homozygous regions. 
 
Individual 
# of genes with 
≥70% bases covered 
# of genes with <70% of 
bases covered 
Average % of 
bases covered 
Family A (II-1) 600 72 89.03% 
Family B (II-2) 601 71 89.01% 
Family B (II-4) 602 70 89.01% 
 
Supplementary Table 7. Summary of exome-sequencing coverage in homozygous regions. There are 672 HGNC 
recognized protein-coding genes found either partially or fully within the predicted shared homozygous regions 
(n=170, present in all sequenced patients from Families A and B). All known Ensembl exons(Hubbard et al., 2009), 
excluding UTRs, were then assessed for coverage, where a base is considered covered if ≥5 short-reads spanned 
this nucleotide. Each sequenced sample has ≥600 of these genes with ≥70% of their bases covered and each 
sample averages nearly 90% nucleotide coverage across these 672 genes.  
 
 
Supplementary Table 8. Seven primary microcephaly loci. 
 
Locus Location Gene Coordinates (NCBI36) MIM 
MCPH1 8p23 Microcephalin (MCPH1) chr8:6,251,529-6,493,434 607117 
MCPH2 19q13 WD repeat-containing protein 62 (WDR62) chr19:41,237,623-41,245,393 613583 
MCPH3 9q33 
CDK5 regulatory subunit-associated protein 2 
(CDK5RAP2) chr9:122,190,968-122,250,225 608201 
MCPH4 15q21 Centrosomal protein, 152-KD (CEP152) chr15:37,900,001-42,700,000 613529 
MCPH5 1q31 
Abnormal spindle-like, microcephaly-
associated (ASPM) chr1:195,319,997-195,382,287 605481 
MCPH6 13q12 Centromeric protein J (CENPJ) chr13:24,354,412-24,395,085 609279 
MCPH7 1p32 SCL/TAL1-interrupting locus (STIL) chr1:47,488,398-47,552,406 181590 
 
Supplementary Table 8. Seven primary microcephaly loci. The previously identified primary microcephaly loci 
and associated information about casual gene at each loci.  
 !  SUPPLEMENTAL INFORMATION Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy.  
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Supplementary Table 9. Predicted homozygous regions overlapping known primary microcephaly loci. 
  







Family A (II-1) chr13:24181657 CENPJ 24354412 24395085 40.674 
Family B (II-4) chr8:6259807 MCPH1 6259807 6364841 105.035 
Family A (II-1) chr8:6289591 MCPH1 6289591 6466364 176.774 
Family A (II-1) chr9:122210554 CDK5RAP2 122210554 122250225 39.672 
 
Supplementary Table 9. Predicted homozygous regions overlapping known primary microcephaly loci. 
Four regions of homozygosity were identified by the PLINK program(Purcell et al., 2007) that overlap one of the 




Supplementary Table 10. Sequencing coverage for exome-sequenced samples from families A-D. 
 
Individual 
Total covered bases 
(MB) % covered bases Average read depth 
Family A (II-1) 36.32 96.1 79.92 
Family B (II-2) 36.30 96.0 63.93 
Family B (II-4) 36.21 95.8 69.59 
Family C (II-3)  51.28 95.0 80 
Family D (II-1)  51.64  97.5 144 
Family D (II-2)  51.37  95.8 126 
Family D (II.4)  51.53  96.3 128 
Family D (II.5)  51.67  97.8 89 
  
Supplementary Table 10. Sequencing coverage for each of the exome-sequenced samples from families 
A-D. A base within the 37.8Mb (families A and B) or the 52 Mb captured region (families C and D) is defined as 
covered if ≥5 short-reads spanned this nucleotide. After accounting for PCR duplicates and reads that did not align 
to captured regions of the reference genome, the average read depth for each sample was greater than 63x and 
greater than 95% of targeted bases were covered in all eight samples.  
 !  
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Appendix B: Multiplex epilepsy family pedigrees1 











































































IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"
IdioUnSzTypTxt = "Epilepsy, unknown type, unknown cause"
IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
















































































































IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
IdioUnSzTypTxt = "Epilepsy, unknown type, unknown cause"
febrile9 = 1
































































































IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"
febrile9 = 1
? IdioUnSzTypTxt = "Not unprovoked, or DK if unprovoked"






































































































































IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
febrile9 = 1
IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"






































































































IdioUnSzTypTxt = "Unprovoked seizure(s), structural/metabolic cause"
acutesz9 = 1
IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"
IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
IdioUnSzTypTxt = "Epilepsy, unknown type, unknown cause"



















































IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
IdioUnSzTypTxt = "Unprovoked seizure(s), structural/metabolic cause"
IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"

























































































804 805 806808 809 810
819 818 820 821 822 823 824 825 826 827
IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
febrile9 = 1
IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"

































































































































IdioUnSzTypTxt = "Epilepsy, unknown type, unknown cause"
febrile9 = 1
IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"
IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
IdioUnSzTypTxt = "Isolated unprovoked seizure, unknown type, unknown"








































































? IdioUnSzTypTxt = "Not unprovoked, or DK if unprovoked"
IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
IdioUnSzTypTxt = "Epilepsy, both generalized and focal, unknown cause"
febrile9 = 1





























































































































































? IdioUnSzTypTxt = "Not unprovoked, or DK if unprovoked"
IdioUnSzTypTxt = "Idiopathic Generalized Epilepsy"
febrile9 = 1









































































































































































































































































































































































































































































































































IdioUnSzTypTxt = "Focal epilepsy, unknown cause"





























































IdioUnSzTypTxt = "Epilepsy, unknown type, unknown cause"
IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
IdioUnSzTypTxt = "Unprovoked seizure(s), structural/metabolic cause"































































































807806 808 809 810 811 812
IdioUnSzTypTxt = "Epilepsy, unknown type, unknown cause"
IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
acutesz9 = 1
febrile9 = 1
IdioUnSzTypTxt = "Unprovoked seizure(s), structural/metabolic cause"


























































































































IdioUnSzTypTxt = "Focal epilepsy, unknown cause"
































































IdioUnSzTypTxt = "Isolated unprovoked seizure, focal, unknown cause"
? IdioUnSzTypTxt = "Not unprovoked, or DK if unprovoked"
IdioUnSzTypTxt = "Epilepsy, unknown type, unknown cause"
IdioUnSzTypTxt = "Focal epilepsy, unknown cause"


































Generalised tonic clonic seizures alone
Epilepsy with myoclonic-atonic seizures




























CHRNA3 variant - R37+
Febrile seizures
Febrile seizures plus





































































Appendix C: Classification of HaloPlex nonsingleton 
variants by Read Position Rank Sum and Quality 
!
Classification of Nonsingleton Variants




































































Classification of Nonsingleton Variants






































































Classification of Nonsingleton Variants










































































































































































































































































































































































































































Classification of Nonsingleton Variants
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